+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transdermal Drug Delivery Market 2024-2028

  • PDF Icon

    Report

  • 168 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5912579
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

The transdermal drug delivery market is segmented as below:

By Application

  • Analgesics
  • Neurological disorders
  • Hormone replacement therapy
  • Cardiovascular disorders
  • Others

By Type

  • Transdermal patches
  • Transdermal semisolids

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

  • Transdermal drug delivery market sizing
  • Transdermal drug delivery market forecast
  • Transdermal drug delivery market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global transdermal drug delivery market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Analgesics - Market size and forecast 2023-2028
Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
6.4 Neurological disorders - Market size and forecast 2023-2028
Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
6.5 Hormone replacement therapy - Market size and forecast 2023-2028
Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
6.6 Cardiovascular disorders - Market size and forecast 2023-2028
Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ billion)
Exhibit 55: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 56: Chart on Type - Market share 2023-2028 (%)
Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
7.3 Transdermal patches - Market size and forecast 2023-2028
Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
7.4 Transdermal semisolids - Market size and forecast 2023-2028
Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ billion)
Exhibit 69: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share by geography 2023-2028 (%)
Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 111: Market opportunity by geography ($ billion)
Exhibit 112: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 3M Co.
Exhibit 119: 3M Co. - Overview
Exhibit 120: 3M Co. - Business segments
Exhibit 121: 3M Co. - Key news
Exhibit 122: 3M Co. - Key offerings
Exhibit 123: 3M Co. - Segment focus
12.4 Boehringer Ingelheim International GmbH
Exhibit 124: Boehringer Ingelheim International GmbH - Overview
Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
Exhibit 126: Boehringer Ingelheim International GmbH - Key news
Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
12.5 Croda International Plc
Exhibit 129: Croda International Plc - Overview
Exhibit 130: Croda International Plc - Business segments
Exhibit 131: Croda International Plc - Key news
Exhibit 132: Croda International Plc - Key offerings
Exhibit 133: Croda International Plc - Segment focus
12.6 Hisamitsu Pharmaceutical Co. Inc.
Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
12.7 Johnson and Johnson
Exhibit 137: Johnson and Johnson - Overview
Exhibit 138: Johnson and Johnson - Business segments
Exhibit 139: Johnson and Johnson - Key news
Exhibit 140: Johnson and Johnson - Key offerings
Exhibit 141: Johnson and Johnson - Segment focus
12.8 Kindeva Drug Delivery L.P.
Exhibit 142: Kindeva Drug Delivery L.P. - Overview
Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service
Exhibit 144: Kindeva Drug Delivery L.P. - Key news
Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings
12.9 Luye Pharma Group Ltd.
Exhibit 146: Luye Pharma Group Ltd. - Overview
Exhibit 147: Luye Pharma Group Ltd. - Business segments
Exhibit 148: Luye Pharma Group Ltd. - Key offerings
Exhibit 149: Luye Pharma Group Ltd. - Segment focus
12.10 Medherant Ltd.
Exhibit 150: Medherant Ltd. - Overview
Exhibit 151: Medherant Ltd. - Product / Service
Exhibit 152: Medherant Ltd. - Key offerings
12.11 Novartis AG
Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
12.12 ProSolus Inc.
Exhibit 157: ProSolus Inc. - Overview
Exhibit 158: ProSolus Inc. - Product / Service
Exhibit 159: ProSolus Inc. - Key offerings
12.13 Purdue Pharma LP
Exhibit 160: Purdue Pharma LP - Overview
Exhibit 161: Purdue Pharma LP - Product / Service
Exhibit 162: Purdue Pharma LP - Key offerings
12.14 Radius Health Inc.
Exhibit 163: Radius Health Inc. - Overview
Exhibit 164: Radius Health Inc. - Product / Service
Exhibit 165: Radius Health Inc. - Key offerings
12.15 Teikoku Seiyaku Co. Ltd.
Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview
Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings
12.16 UCB SA
Exhibit 169: UCB SA - Overview
Exhibit 170: UCB SA - Product / Service
Exhibit 171: UCB SA - Key offerings
12.17 Viatris Inc.
Exhibit 172: Viatris Inc. - Overview
Exhibit 173: Viatris Inc. - Business segments
Exhibit 174: Viatris Inc. - Key news
Exhibit 175: Viatris Inc. - Key offerings
Exhibit 176: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibits 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 54: Market opportunity by Application ($ billion)
Exhibits 55: Data Table on Market opportunity by Application ($ billion)
Exhibits 56: Chart on Type - Market share 2023-2028 (%)
Exhibits 57: Data Table on Type - Market share 2023-2028 (%)
Exhibits 58: Chart on Comparison by Type
Exhibits 59: Data Table on Comparison by Type
Exhibits 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Type ($ billion)
Exhibits 69: Data Table on Market opportunity by Type ($ billion)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share by geography 2023-2028 (%)
Exhibits 72: Data Table on Market share by geography 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity by geography ($ billion)
Exhibits 112: Data Tables on Market opportunity by geography ($ billion)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: 3M Co. - Overview
Exhibits 120: 3M Co. - Business segments
Exhibits 121: 3M Co. - Key news
Exhibits 122: 3M Co. - Key offerings
Exhibits 123: 3M Co. - Segment focus
Exhibits 124: Boehringer Ingelheim International GmbH - Overview
Exhibits 125: Boehringer Ingelheim International GmbH - Business segments
Exhibits 126: Boehringer Ingelheim International GmbH - Key news
Exhibits 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 128: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 129: Croda International Plc - Overview
Exhibits 130: Croda International Plc - Business segments
Exhibits 131: Croda International Plc - Key news
Exhibits 132: Croda International Plc - Key offerings
Exhibits 133: Croda International Plc - Segment focus
Exhibits 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits 137: Johnson and Johnson - Overview
Exhibits 138: Johnson and Johnson - Business segments
Exhibits 139: Johnson and Johnson - Key news
Exhibits 140: Johnson and Johnson - Key offerings
Exhibits 141: Johnson and Johnson - Segment focus
Exhibits 142: Kindeva Drug Delivery L.P. - Overview
Exhibits 143: Kindeva Drug Delivery L.P. - Product / Service
Exhibits 144: Kindeva Drug Delivery L.P. - Key news
Exhibits 145: Kindeva Drug Delivery L.P. - Key offerings
Exhibits 146: Luye Pharma Group Ltd. - Overview
Exhibits 147: Luye Pharma Group Ltd. - Business segments
Exhibits 148: Luye Pharma Group Ltd. - Key offerings
Exhibits 149: Luye Pharma Group Ltd. - Segment focus
Exhibits 150: Medherant Ltd. - Overview
Exhibits 151: Medherant Ltd. - Product / Service
Exhibits 152: Medherant Ltd. - Key offerings
Exhibits 153: Novartis AG - Overview
Exhibits 154: Novartis AG - Business segments
Exhibits 155: Novartis AG - Key offerings
Exhibits 156: Novartis AG - Segment focus
Exhibits 157: ProSolus Inc. - Overview
Exhibits 158: ProSolus Inc. - Product / Service
Exhibits 159: ProSolus Inc. - Key offerings
Exhibits 160: Purdue Pharma LP - Overview
Exhibits 161: Purdue Pharma LP - Product / Service
Exhibits 162: Purdue Pharma LP - Key offerings
Exhibits 163: Radius Health Inc. - Overview
Exhibits 164: Radius Health Inc. - Product / Service
Exhibits 165: Radius Health Inc. - Key offerings
Exhibits 166: Teikoku Seiyaku Co. Ltd. - Overview
Exhibits 167: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibits 168: Teikoku Seiyaku Co. Ltd. - Key offerings
Exhibits 169: UCB SA - Overview
Exhibits 170: UCB SA - Product / Service
Exhibits 171: UCB SA - Key offerings
Exhibits 172: Viatris Inc. - Overview
Exhibits 173: Viatris Inc. - Business segments
Exhibits 174: Viatris Inc. - Key news
Exhibits 175: Viatris Inc. - Key offerings
Exhibits 176: Viatris Inc. - Segment focus
Exhibits 177: Inclusions checklist
Exhibits 178: Exclusions checklist
Exhibits 179: Currency conversion rates for US$
Exhibits 180: Research methodology
Exhibits 181: Validation techniques employed for market sizing
Exhibits 182: Information sources
Exhibits 183: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global transdermal drug delivery market: 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing interest in transdermal medicines.'

According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • Boehringer Ingelheim International GmbH
  • Croda International Plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Johnson and Johnson
  • Kindeva Drug Delivery L.P.
  • Luye Pharma Group Ltd.
  • Medherant Ltd.
  • Novartis AG
  • ProSolus Inc.
  • Purdue Pharma LP
  • Radius Health Inc.
  • Rusan Pharma Ltd.
  • Sparsha Pharma International Pvt. Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • UCB SA
  • Viatris Inc.